DOJ asks Supreme Court to remand Medicaid work requirement cases

Feb 24, 2021 - 03:32 PM
court-900x400

The Department of Justice this week asked the U.S. Supreme Court to remand the appealed Arkansas and New Hampshire cases to the Department of Health and Human Services to determine the appropriate path forward for the demonstration projects.

“HHS has now made a preliminary determination that allowing work-related requirements to take effect in Arkansas and New Hampshire would not promote the objectives of the Medicaid program and has commenced a process to determine whether to withdraw its approvals of those requirements,” the motion states. “The agency actions under review in this Court have accordingly been overtaken by these changed circumstances. In addition, the approval of Arkansas’s work-related requirements will expire by its own terms on December 31, 2021.” 

The Department also asked the Supreme Court to remove from its calendar the oral arguments in the cases scheduled for March 29.

The Arkansas and New Hampshire demonstration projects are among more than a dozen state Medicaid projects approved by or pending before HHS that include work-related requirements, which are not currently operative. HHS recently informed Arkansas, New Hampshire and other states with previously approved work-related requirements that it was determining whether to withdraw approval of those requirements.  

Related News Articles

Headline
Administration rescinds memo pausing federal grants, loans and other financial assistance programs
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
White House pauses federal grants, other programs implicated by executive orders; OMB says Medicare and Medicaid not affected by pause
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
CMS announces two drug manufacturers to participate in CGT Access Model 
The Centers for Medicare & Medicaid Services Dec. 4 announced that drug manufacturers bluebird bio, inc. (manufacturer of Lyfgenia) and Vertex…
Headline
CMS to allow Medicaid, CHIP coverage for IHS facilities, tribal communities 
The Centers for Medicare & Medicaid Services Oct. 16 approved section 1115 demonstration amendments which will allow Medicaid and Children's Health…
Headline
CMS releases guidance for states to meet Early and Periodic Screening, Diagnostic and Treatment requirements under Medicaid and CHIP
The Centers for Medicare & Medicaid Services Sept. 26 released guidance on state compliance with the Early and Periodic Screening, Diagnostic and Treatment…
Headline
CMS releases state funding notice for participants in gene therapy model 
The Centers for Medicare & Medicaid Services Aug. 15 released a state funding notice for the Cell and Gene Therapy Access Model. The CGT Access Model will…